Skip to main content
logo
ResMed Inc. (ASX:RMD)
Australia flag Australia · Delayed Price · Currency is AUD
43.02
0.00 (0.00%)
Aug 8, 2025, 4:10 PM AEST

Paramount Global Revenue

In the fiscal year ending June 30, 2025, ResMed had annual revenue of $5.15B USD with 9.84% growth. ResMed had revenue of $1.35B in the quarter ending June 30, 2025, with 10.20% growth.

Revenue
$5.15B
Revenue Growth
+9.84%
P/S Ratio
8.11
Revenue / Employee
$515.66K
Employees
9,980
Market Cap
63.68B

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year EndRevenueChangeGrowth
Jun 30, 20255.15B461.03M9.84%
Jun 30, 20244.69B462.30M10.95%
Jun 30, 20234.22B644.87M18.02%
Jun 30, 20223.58B381.30M11.93%
Jun 30, 20213.20B239.81M8.11%
Jun 30, 2020 Pro Pro Pro
Jun 30, 2019 Pro Pro Pro
Jun 30, 2018 Pro Pro Pro
Jun 30, 2017 Pro Pro Pro
Jun 30, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
CSL Limited24.61B
Pro Medicus184.58M
Cochlear2.31B
Sonic Healthcare9.33B
Ramsay Health Care17.12B
Telix Pharmaceuticals783.21M
Ansell3.00B
Mesoblast9.16M
Revenue Rankings

ResMed News

More News